Trademarkia Logo

Canada

C$
b
APPROVED

on 3 Feb 2025

Last Applicant/ Owned by

Bridgebio Pharma, Inc.

3160 Porter Dr., Suite 250 Palo Alto CA 94304

US

Serial Number

2237110 filed on 20th Dec 2022

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

b

Trademark usage description

pharmaceuticals for use in the treatment of oncological diseases and disorders, cardiological diseases and disorders, dermatological diseases and diso Read More

Vienna Information


26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

Classification Information


Class [005]
Pharmaceuticals for use in the treatment of oncological diseases and disorders, cardiological diseases and disorders, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases, neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, and cerebral palsy, genetic diseases and disorders, orthopedic diseases and disorders, namely, arthritis, osteoporosis, fibromyalgia, and metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity, hyperlipidemia, insulin resistance, metabolic syndrome.


Classification kind code

11

Class [042]
Pharmaceutical research and development services.


Classification kind code

11

Mark Details


Serial Number

2237110

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 135
on 14th Mar 2024
Amendment to Application
Submitted for opposition 22
on 8th Jan 2024
Search Recorded
Submitted for opposition 20
on 8th Jan 2024
Examiner's First Report
Submitted for opposition 223
on 8th Jan 2024
Total Provisional Refusal
Submitted for opposition 256
on 4th Dec 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 2th Feb 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 1st Feb 2023
Formalized
Submitted for opposition 1
on 1st Feb 2023
Created
Submitted for opposition 228
on 20th Dec 2022
International Registration
Submitted for opposition 30
on 20th Dec 2022
Filed